))
The Benefits of Biosimilar Drugs
Manage episode 345546635 series 3409958
Content provided by UnitedHealth Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UnitedHealth Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
The use of biosimilar drugs – which mimic existing biologic drugs – could reduce U.S. drug costs by more than $100 billion over the next five years. However, there are still challenges in getting these lower-cost medications into the hands of patients. Savitha Vivian, Senior Vice President, Clinical and Formulary Services at Optum Rx, discusses the pipeline of biosimilar drugs – including a highly-anticipated 2023 launch – and how broader use of biosimilars could improve prescription drug affordability for patients.
40 episodes
Share
